Brind.

Shopify and Teva Set to Join Russell Indexes

1 report, 1 independent Updated Tue 16:45
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Shopify and Teva Pharmaceutical Industries Ltd. are expected to join Russell indexes. Two months ago, Teva completed a technical move to transition its ordinary shares to a direct listing on the New York Stock Exchange, rather than trading in American Depositary Shares. LSEG, the operator of the Russell indices, has published a preliminary list of anticipated index adjustments, which includes Teva joining the Russell 1000 index of large-cap companies.

From globes.co.il

Why it matters

Some supportBrind's analysis of the reports

Inclusion in the index is expected to generate demand for shares of both companies. As of December 2025, nearly $12.5 trillion in assets were benchmarked against Russell indices, with the aggregate market cap of included companies reaching about $77.5 trillion.

From globes.co.il

Who's involved

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • ShopifySpeculative

    Shopify shares could see increased demand and market valuation due to index inclusion.

  • Teva shares could see increased demand due to its index inclusion and direct listing.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped